Epidermal barrier formation and recovery in skin disorders.

Skin is at the interface between the complex physiology of the body and the external, often hostile, environment, and the semipermeable epidermal barrier prevents both the escape of moisture and the entry of infectious or toxic substances. Newborns with rare congenital barrier defects underscore the skin's essential role in a terrestrial environment and demonstrate the compensatory responses evoked ex utero to reestablish a barrier. Common inflammatory skin disorders such as atopic dermatitis and psoriasis exhibit decreased barrier function, and recent studies suggest that the complex response of epidermal cells to barrier disruption may aggravate, maintain, or even initiate such conditions. Either aiding barrier reestablishment or dampening the epidermal stress response may improve the treatment of these disorders. This Review discusses the molecular regulation of the epidermal barrier as well as causes and potential treatments for defects of barrier formation and proposes that medical management of barrier disruption may positively affect the course of common skin disorders.

[1]  Elaine Fuchs,et al.  Klf4 is a transcription factor required for establishing the barrier function of the skin , 1999, Nature Genetics.

[2]  Wing Hung Wong,et al.  Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. , 2003, Physiological genomics.

[3]  P. Elias,et al.  The aged epidermal permeability barrier: basis for functional abnormalities. , 2002, Clinics in geriatric medicine.

[4]  J. Weissenbach,et al.  Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2. , 2003, Human molecular genetics.

[5]  M. Raghunath,et al.  Self-healing collodion baby: a dynamic phenotype explained by a particular transglutaminase-1 mutation. , 2003, The Journal of investigative dermatology.

[6]  G. Abecasis,et al.  Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci , 2001, Nature Genetics.

[7]  C. Carcassi,et al.  Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21. , 2001, The Journal of investigative dermatology.

[8]  P. Demoly,et al.  [A revised nomenclature for allergy]. , 2004, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[9]  J. Bousquet,et al.  A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task force , 2001, Allergy.

[10]  A. Burden,et al.  Upregulation of connexin 26 is a feature of keratinocyte differentiation in hyperproliferative epidermis, vaginal epithelium, and buccal epithelium. , 1999, The Journal of investigative dermatology.

[11]  H. Tagami,et al.  Functional analyses of the stratum corneum in scars. Sequential studies after injury and comparison among keloids, hypertrophic scars, and atrophic scars. , 1996, Archives of dermatology.

[12]  P. Elias,et al.  Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. , 2003, The Journal of investigative dermatology.

[13]  D. Kelsell,et al.  Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis. , 2005, American journal of human genetics.

[14]  H. Tojo,et al.  Alteration of the 4-sphingenine scaffolds of ceramides in keratinocyte-specific Arnt-deficient mice affects skin barrier function. , 2003, The Journal of clinical investigation.

[15]  S. Wahl,et al.  Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis , 2002, Oncogene.

[16]  H. Schwarz,et al.  E‐cadherin is essential for in vivo epidermal barrier function by regulating tight junctions , 2005, The EMBO journal.

[17]  P. Elias,et al.  Barrier function regulates epidermal DNA synthesis. , 1991, The Journal of clinical investigation.

[18]  B. Nickoloff,et al.  Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. , 1994, Journal of the American Academy of Dermatology.

[19]  J. Gordon,et al.  Molecular analysis of commensal host-microbial relationships in the intestine. , 2001, Science.

[20]  J. Segre,et al.  Long-range comparison of human and mouse Sprr loci to identify conserved noncoding sequences involved in coordinate regulation. , 2004, Genome research.

[21]  D. Robinson,et al.  Thymic Stromal Lymphopoietin Expression Is Increased in Asthmatic Airways and Correlates with Expression of Th2-Attracting Chemokines and Disease Severity1 , 2005, The Journal of Immunology.

[22]  J. Saurat,et al.  Upregulation of connexin 26 between keratinocytes of psoriatic lesions. , 1998, The Journal of investigative dermatology.

[23]  K. Sandhoff,et al.  The epidermal barrier function is dependent on the serine protease CAP1/Prss8 , 2005, The Journal of cell biology.

[24]  Elaine Fuchs,et al.  Getting under the skin of epidermal morphogenesis , 2002, Nature Reviews Genetics.

[25]  Lisa A. Beck,et al.  Keratinocytes in Atopic dermatitis: Inflammatory signals , 2004, Current allergy and asthma reports.

[26]  James A. Cuff,et al.  Genome sequence, comparative analysis and haplotype structure of the domestic dog , 2005, Nature.

[27]  F. Watt,et al.  Designer skin: lineage commitment in postnatal epidermis. , 2002, Trends in cell biology.

[28]  C. Bodemer,et al.  Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome , 2000, Nature Genetics.

[29]  D. Metzger,et al.  TAF10 is required for the establishment of skin barrier function in foetal, but not in adult mouse epidermis. , 2005, Developmental biology.

[30]  S. Bale,et al.  Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris , 2006, Nature Genetics.

[31]  C. Byrne,et al.  Differentially expressed late constituents of the epidermal cornified envelope , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  E. Wagner,et al.  Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins , 2005, Nature.

[33]  Francesca Chiaromonte,et al.  Evaluation of regulatory potential and conservation scores for detecting cis-regulatory modules in aligned mammalian genome sequences. , 2005, Genome research.

[34]  D. Stolz,et al.  Small proline-rich proteins 2 are noncoordinately upregulated by IL-6/STAT3 signaling after bile duct ligation , 2005, Laboratory Investigation.

[35]  S. Ziegler,et al.  Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin , 2005, The Journal of experimental medicine.

[36]  Xin-Hua Feng,et al.  Latent TGFβ1 overexpression in keratinocytes results in a severe psoriasis‐like skin disorder , 2004, The EMBO journal.

[37]  P. Elias,et al.  Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. , 1996, The Journal of investigative dermatology.

[38]  J. Carulli,et al.  Peptidoglycan recognition proteins Pglyrp3 and Pglyrp4 are encoded from the epidermal differentiation complex and are candidate genes for the Psors4 locus on chromosome 1q21 , 2006, Human Genetics.

[39]  P. Steinert.  The Complexity and Redundancy of Epithelial Barrier Function , 2000, The Journal of cell biology.

[40]  S. Jane,et al.  A Homolog of Drosophila grainy head Is Essential for Epidermal Integrity in Mice , 2005, Science.

[41]  M. Lathrop,et al.  Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3. , 2006, Human molecular genetics.

[42]  J. Clifford,et al.  Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model , 2005, Nature Medicine.

[43]  W. Leonard,et al.  A role for TSLP in the development of inflammation in an asthma model , 2005, The Journal of experimental medicine.

[44]  J. Ross,et al.  Small proline‐rich protein 1A is a gp130 pathway‐ and stress‐inducible cardioprotective protein , 2004, The EMBO journal.

[45]  P. Elias,et al.  Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. , 1992, The Journal of clinical investigation.

[46]  S. Bale,et al.  Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichthyosis , 1995, Nature Genetics.

[47]  J. R. McMillan,et al.  Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer. , 2005, The Journal of clinical investigation.

[48]  G. Abecasis,et al.  Gene polymorphism in Netherton and common atopic disease , 2001, Nature Genetics.

[49]  Kathleen M. Smith,et al.  Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP , 2002, Nature Immunology.

[50]  A. Sonnenberg,et al.  Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity , 2005, Nature Genetics.

[51]  P. Elias,et al.  Stratum corneum structure and function correlates with phenotype in psoriasis. , 1996, The Journal of investigative dermatology.

[52]  P. Elias,et al.  The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. , 1995, The Journal of clinical investigation.

[53]  Y. Kalia,et al.  Development of skin barrier function in premature infants. , 1998, The Journal of investigative dermatology.

[54]  P. Elias,et al.  Heterogeneity in autosomal recessive ichthyosis. Clinical and biochemical differentiation of lamellar ichthyosis and nonbullous congenital ichthyosiform erythroderma. , 1985, Archives of dermatology.

[55]  J. D. Engel,et al.  Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation , 2003, Nature Genetics.

[56]  Anil Mishra,et al.  Expression and regulation of small proline-rich protein 2 in allergic inflammation. , 2005, American journal of respiratory cell and molecular biology.

[57]  H. Hönigsmann,et al.  Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. , 2003, Journal of the American Academy of Dermatology.

[58]  Colin N A Palmer,et al.  Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis , 2006, Nature Genetics.

[59]  K. Feingold,et al.  Glucocorticoids accelerate fetal maturation of the epidermal permeability barrier in the rat. , 1993, The Journal of clinical investigation.

[60]  Nicola J. Rinaldi,et al.  Transcriptional Regulatory Networks in Saccharomyces cerevisiae , 2002, Science.

[61]  H. D. Liggitt,et al.  Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice , 2005, Nature Immunology.

[62]  Tetsuo Noda,et al.  Claudin-based tight junctions are crucial for the mammalian epidermal barrier , 2002, The Journal of cell biology.

[63]  Donald Y M Leung,et al.  Amendment history : Erratum ( April 2004 ) New insights into atopic dermatitis , 2018 .

[64]  P. Elias,et al.  Pathophysiologic basis for growth failure in children with ichthyosis: an evaluation of cutaneous ultrastructure, epidermal permeability barrier function, and energy expenditure. , 2004, The Journal of pediatrics.

[65]  P. Elias,et al.  Epidermal lipids, barrier function, and desquamation. , 1983, The Journal of investigative dermatology.

[66]  J. Sundberg,et al.  Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. , 2000, The Journal of investigative dermatology.

[67]  J. Segre,et al.  Mouse Sprr locus: a tandem array of coordinately regulated genes , 2003, Mammalian Genome.

[68]  M. Hashida,et al.  Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase). , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[69]  R. Geha,et al.  Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. , 1998, The Journal of clinical investigation.

[70]  M. Lathrop,et al.  Mutations in ichthyin a new gene on chromosome 5q33 in a new form of autosomal recessive congenital ichthyosis. , 2004, Human molecular genetics.

[71]  P. Steinert,et al.  Bricks and mortar of the epidermal barrier , 1999, Experimental & Molecular Medicine.

[72]  M. Itoh,et al.  Molecular architecture of tight junctions of periderm differs from that of the maculae occludentes of epidermis. , 2002, The Journal of investigative dermatology.

[73]  J. Segre.  Complex redundancy to build a simple epidermal permeability barrier. , 2003, Current opinion in cell biology.

[74]  L. Muglia,et al.  Glucocorticoid deficiency delays stratum corneum maturation in the fetal mouse. , 1998, The Journal of investigative dermatology.

[75]  N. Caplen,et al.  Defining and assaying RNAi in mammalian cells. , 2005, Molecular cell.

[76]  A. Steven,et al.  Lessons from Loricrin-Deficient Mice , 2000, The Journal of cell biology.

[77]  C. Byrne,et al.  Patterned acquisition of skin barrier function during development. , 1998, Development.

[78]  F. Nestle,et al.  Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. , 2004, The Journal of clinical investigation.

[79]  M. Ponec,et al.  Mutations of keratinocyte transglutaminase in lamellar ichthyosis , 1995, Science.

[80]  P. Steinert,et al.  Epithelial barrier function: assembly and structural features of the cornified cell envelope. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[81]  A. Paller,et al.  Atopic dermatitis and the atopic march. , 2003, The Journal of allergy and clinical immunology.

[82]  J. Segre,et al.  Connexin 26 regulates epidermal barrier and wound remodeling and promotes psoriasiform response. , 2006, The Journal of clinical investigation.

[83]  T. Takizawa,et al.  Development of ichthyosiform skin compensates for defective permeability barrier function in mice lacking transglutaminase 1. , 2002, The Journal of clinical investigation.

[84]  G. Richard.  Connexin disorders of the skin. , 2005, Clinical Dermatology.

[85]  G. Richard.  Molecular genetics of the ichthyoses , 2004, American journal of medical genetics. Part C, Seminars in medical genetics.

[86]  J. Weissenbach,et al.  Lipoxygenase-3 (ALOXE3) and 12(R)-lipoxygenase (ALOX12B) are mutated in non-bullous congenital ichthyosiform erythroderma (NCIE) linked to chromosome 17p13.1. , 2002, Human molecular genetics.

[87]  W. Cookson.  The immunogenetics of asthma and eczema: a new focus on the epithelium , 2004, Nature Reviews Immunology.

[88]  Ann-Marie Broome,et al.  S100 Protein Subcellular Localization During Epidermal Differentiation and Psoriasis , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[89]  Paul T. Groth,et al.  The ENCODE (ENCyclopedia Of DNA Elements) Project , 2004, Science.

[90]  Jurg Ott,et al.  A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis , 2003, Nature Genetics.

[91]  J. Segre,et al.  Ectopic expression of Kruppel like factor 4 (Klf4) accelerates formation of the epidermal permeability barrier , 2003, Development.